Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines
Bethesda, Maryland–(ENEWSPF)–August 28, 2014. Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The early-stage trial will begin initial human testing of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and will evaluate the experimental vaccine’s safety and ability…
